Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.

Tan M, Jiang X.

Nanomedicine (Lond). 2012 Jun;7(6):889-97. doi: 10.2217/nnm.12.62. Review.

2.

Vaccine against norovirus.

Tan M, Jiang X.

Hum Vaccin Immunother. 2014;10(6):1449-56. doi: 10.4161/hv.28626. Epub 2014 May 5. Review.

PMID:
24718366
3.

Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis.

Richardson C, Bargatze RF, Goodwin R, Mendelman PM.

Expert Rev Vaccines. 2013 Feb;12(2):155-67. doi: 10.1586/erv.12.145. Review.

PMID:
23414407
4.

Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children.

Payne DC, Parashar UD, Lopman BA.

Curr Opin Pediatr. 2015 Feb;27(1):105-9. doi: 10.1097/MOP.0000000000000166. Review.

5.

Norovirus.

Robilotti E, Deresinski S, Pinsky BA.

Clin Microbiol Rev. 2015 Jan;28(1):134-64. doi: 10.1128/CMR.00075-14. Review.

6.

Viral shape-shifting: norovirus evasion of the human immune system.

Donaldson EF, Lindesmith LC, Lobue AD, Baric RS.

Nat Rev Microbiol. 2010 Mar;8(3):231-41. doi: 10.1038/nrmicro2296. Epub 2010 Feb 2. Review.

PMID:
20125087
7.

New interventions against human norovirus: progress, opportunities, and challenges.

Li J, Predmore A, Divers E, Lou F.

Annu Rev Food Sci Technol. 2012;3:331-52. doi: 10.1146/annurev-food-022811-101234. Epub 2011 Nov 7. Review.

PMID:
22385167
8.

Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations.

Donaldson EF, Lindesmith LC, Lobue AD, Baric RS.

Immunol Rev. 2008 Oct;225:190-211. doi: 10.1111/j.1600-065X.2008.00680.x. Review.

PMID:
18837783
9.

Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.

Aliabadi N, Lopman BA, Parashar UD, Hall AJ.

Expert Rev Vaccines. 2015;14(9):1241-53. doi: 10.1586/14760584.2015.1073110. Epub 2015 Jul 29. Review.

PMID:
26224658
10.

Present status of rotavirus vaccine.

Kelkar SD.

Indian Pediatr. 1994 Aug;31(8):957-69. Review. No abstract available.

PMID:
7883349
11.

Is there still space for the implementation of antisepsis and disinfection to prevent rotavirus and norovirus gastroenteritis outbreaks?

Protano C, Vitali M, Raitano A, Sancin A, Agolini G.

J Prev Med Hyg. 2008 Mar;49(1):55-60. Review. No abstract available.

PMID:
18792534
12.

Lactoferrin for prevention of common viral infections.

Wakabayashi H, Oda H, Yamauchi K, Abe F.

J Infect Chemother. 2014 Nov;20(11):666-71. doi: 10.1016/j.jiac.2014.08.003. Epub 2014 Aug 30. Review.

13.

The rotavirus vaccine.

Offit PA.

J Clin Virol. 1998 Dec;11(3):155-9. Review.

PMID:
9949951
14.

[Norovirus (infants/children)].

Onishi S.

Nihon Rinsho. 2012 Aug;70(8):1366-70. Review. Japanese.

PMID:
22894074
15.

Mendelian resistance to human norovirus infections.

Le Pendu J, Ruvoën-Clouet N, Kindberg E, Svensson L.

Semin Immunol. 2006 Dec;18(6):375-86. Epub 2006 Sep 14. Review.

PMID:
16973373
16.

The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.

Clark HF, Offit PA, Plotkin SA, Heaton PM.

Pediatr Infect Dis J. 2006 Jul;25(7):577-83. Review.

PMID:
16804425
17.

Norovirus immunology: Of mice and mechanisms.

Newman KL, Leon JS.

Eur J Immunol. 2015 Oct;45(10):2742-57. doi: 10.1002/eji.201545512. Epub 2015 Aug 25. Review.

PMID:
26256101
18.

Review of rotavirus vaccine trials in Finland.

Vesikari T, Joensuu J.

J Infect Dis. 1996 Sep;174 Suppl 1:S81-7. Review.

19.

[Genetic susceptibility to norovirus infection].

Ruvoën N, Le Pendu J.

Pathol Biol (Paris). 2013 Jan;61(1):28-35. doi: 10.1016/j.patbio.2013.01.002. Epub 2013 Feb 8. Review. French.

PMID:
23399413
20.

[Vaccine development for Norwalk virus].

Nakata S.

Nihon Rinsho. 2002 Jun;60(6):1222-7. Review. Japanese.

PMID:
12078098
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk